Literature DB >> 3793436

Combination of furosemide and metolazone in the treatment of severe congestive heart failure.

I Grosskopf, M Rabinovitz, J B Rosenfeld.   

Abstract

Ten patients with severe congestive heart failure (6 women and 4 men, aged 67 +/- 4.35 years) were given diuretic therapy with either furosemide or metolazone followed by combined therapy of both agents. We found that the furosemide-metolazone combination induced greater natriuresis, urinary output and weight loss than did furosemide or metolazone alone. Notably, none of our patients displayed profound diuresis, severe hyponatremia or deterioration of renal function, found previously in high-risk patients treated with this combination.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3793436

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  4 in total

Review 1.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 2.  Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships.

Authors:  D A Sica; T W Gehr
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

Review 3.  The Initial Evaluation and Management of a Patient with Heart Failure.

Authors:  Jamael Hoosain; Jabar Whittier; Farhan Hasni; Shelley Hankins
Journal:  Curr Cardiol Rep       Date:  2017-09-06       Impact factor: 2.931

4.  Combination diuretic treatment in severe heart failure: a randomised controlled trial.

Authors:  K S Channer; K A McLean; P Lawson-Matthew; M Richardson
Journal:  Br Heart J       Date:  1994-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.